Voyager Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Voyager Therapeutics, Inc. (VYGR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.65 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 15.00K shares, a 81.73% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 81.10K shares, a 75.07% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was -122.03K shares, a 148.37% decline year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 2.33M shares, a 33.22% increase year-over-year.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.30M shares, a 4.36% decline from fiscal 2024.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.41M shares, a 3.46% increase from fiscal 2023.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.33M shares, a 36.79% decline from fiscal 2022.
- Voyager Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.68M shares, a 142.46% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 2.65M shares 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 96.10K shares derived: sum of 2 quarters · filed 2026-03-09 | -25.93K shares derived: sum of 3 quarters · filed 2026-03-09 | 2.30M shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 81.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -40.93K shares derived: sum of 2 quarters · filed 2025-11-10 | 2.29M shares 10-Q · filed 2025-11-10 | 2.37M shares derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-06-30 | -122.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 2.21M shares 10-Q · filed 2025-08-06 | 2.29M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.61M shares derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-03-31 | 2.33M shares 10-Q · filed 2026-05-07 | 1.91M shares 10-Q · filed 2025-05-06 | 2.41M shares derived: sum of 2 quarters · filed 2026-05-07 | 2.74M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.99M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 82.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 407.40K shares derived: sum of 2 quarters · filed 2025-03-11 | 659.70K shares derived: sum of 3 quarters · filed 2025-03-11 | 2.41M shares 10-K · filed 2025-03-11 | |
| 2024-09-30 | 325.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 577.60K shares derived: sum of 2 quarters · filed 2024-11-12 | 2.33M shares 10-Q · filed 2024-11-12 | 2.40M shares derived: sum of 4 quarters · filed 2024-11-12 | |
| 2024-06-30 | 252.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 2.00M shares 10-Q · filed 2024-08-06 | 2.08M shares derived: sum of 3 quarters · filed 2024-08-06 | 2.66M shares derived: sum of 4 quarters · filed 2024-08-06 | |
| 2024-03-31 | 1.75M shares 10-Q · filed 2024-05-13 | 1.82M shares derived: sum of 2 quarters · filed 2024-05-13 | 2.41M shares derived: sum of 3 quarters · filed 2024-05-13 | 2.72M shares derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-12-31 | 76.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 663.60K shares derived: sum of 2 quarters · filed 2024-02-28 | 968.60K shares derived: sum of 3 quarters · filed 2024-02-28 | 2.33M shares 10-K · filed 2024-02-28 | |
| 2023-09-30 | 587.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 892.20K shares derived: sum of 2 quarters · filed 2023-11-06 | 2.25M shares 10-Q · filed 2023-11-06 | 2.43M shares derived: sum of 4 quarters · filed 2023-11-06 | |
| 2023-06-30 | 305.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 1.66M shares 10-Q · filed 2023-08-03 | 1.84M shares derived: sum of 3 quarters · filed 2023-08-03 | 2.38M shares derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | 1.36M shares 10-Q · filed 2023-05-09 | 1.53M shares derived: sum of 2 quarters · filed 2023-05-09 | 2.07M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.27M shares derived: sum of 4 quarters · filed 2023-05-09 | |
| 2022-12-31 | 176.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 716.00K shares derived: sum of 2 quarters · filed 2023-03-07 | 915.40K shares derived: sum of 3 quarters · filed 2023-03-07 | 3.68M shares 10-K · filed 2023-03-07 | |
| 2022-09-30 | 539.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 739.00K shares derived: sum of 2 quarters · filed 2022-11-08 | 3.50M shares 10-Q · filed 2022-11-08 | 3.61M shares derived: sum of 4 quarters · filed 2022-11-08 | |
| 2022-06-30 | 199.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 2.97M shares 10-Q · filed 2022-08-04 | 3.07M shares derived: sum of 3 quarters · filed 2022-08-04 | 3.10M shares derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | 2.77M shares 10-Q · filed 2022-05-04 | 2.87M shares derived: sum of 2 quarters · filed 2022-05-04 | 2.90M shares derived: sum of 3 quarters · filed 2022-05-04 | 3.25M shares derived: sum of 4 quarters · filed 2022-05-04 | |
| 2021-12-31 | 106.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 131.55K shares derived: sum of 2 quarters · filed 2022-03-08 | 486.52K shares derived: sum of 3 quarters · filed 2022-03-08 | 1.52M shares 10-K · filed 2022-03-08 | |
| 2021-09-30 | 25.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 380.23K shares derived: sum of 2 quarters · filed 2021-11-02 | 1.41M shares 10-Q · filed 2021-11-02 | 1.58M shares derived: sum of 4 quarters · filed 2021-11-02 | |
| 2021-06-30 | 354.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.39M shares 10-Q · filed 2021-08-09 | 1.56M shares derived: sum of 3 quarters · filed 2021-08-09 | 1.80M shares derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | 1.03M shares 10-Q · filed 2021-05-10 | 1.20M shares derived: sum of 2 quarters · filed 2021-05-10 | 1.45M shares derived: sum of 3 quarters · filed 2021-05-10 | 1.69M shares derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | 172.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 413.36K shares derived: sum of 2 quarters · filed 2021-02-25 | 661.49K shares derived: sum of 3 quarters · filed 2021-02-25 | 1.56M shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 240.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 489.05K shares derived: sum of 2 quarters · filed 2020-11-09 | 1.39M shares 10-Q · filed 2020-11-09 | 1.55M shares derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-06-30 | 248.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 1.15M shares 10-Q · filed 2020-08-10 | 1.31M shares derived: sum of 3 quarters · filed 2020-08-10 | 1.54M shares derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | 899.09K shares 10-Q · filed 2020-05-06 | 1.06M shares derived: sum of 2 quarters · filed 2020-05-06 | 1.29M shares derived: sum of 3 quarters · filed 2020-05-06 | 1.85M shares derived: sum of 4 quarters · filed 2020-05-06 | |
| 2019-12-31 | 165.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 392.96K shares derived: sum of 2 quarters · filed 2020-03-03 | 950.54K shares derived: sum of 3 quarters · filed 2020-03-03 | 1.70M shares 10-K · filed 2020-03-03 | |
| 2019-09-30 | 227.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 785.17K shares derived: sum of 2 quarters · filed 2019-11-06 | 1.54M shares 10-Q · filed 2019-11-06 | 1.72M shares derived: sum of 4 quarters · filed 2019-11-06 | |
| 2019-06-30 | 557.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 1.31M shares 10-Q · filed 2019-08-09 | 1.50M shares derived: sum of 3 quarters · filed 2019-08-09 | 2.34M shares derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | 753.34K shares 10-Q · filed 2019-05-07 | 939.04K shares derived: sum of 2 quarters · filed 2019-05-07 | 1.79M shares derived: sum of 3 quarters · filed 2019-05-07 | 2.04M shares derived: sum of 4 quarters · filed 2019-05-07 | |
| 2018-12-31 | 185.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 1.03M shares derived: sum of 2 quarters · filed 2019-02-26 | 1.29M shares derived: sum of 3 quarters · filed 2019-02-26 | 2.22M shares 10-K · filed 2019-02-26 | |
| 2018-09-30 | 846.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 1.10M shares derived: sum of 2 quarters · filed 2018-11-07 | 2.03M shares 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | 258.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 1.18M shares 10-Q · filed 2018-08-07 | |||
| 2018-03-31 | 926.09K shares 10-Q · filed 2018-05-10 | ||||
| 2017-09-30 | 285.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 497.20K shares derived: sum of 2 quarters · filed 2017-11-02 | 1.54M shares 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | 211.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 1.26M shares 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 1.04M shares 10-Q · filed 2017-05-09 | ||||
| 2016-09-30 | 90.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 290.80K shares derived: sum of 2 quarters · filed 2016-11-10 | 896.61K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 200.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 806.01K shares 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | 605.81K shares 10-Q · filed 2016-05-12 | ||||
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |